WKN DE: A2AJKS / ISIN: FR0013154002

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Orderbuch
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Sartorius Stedim Biotech Times and Sales (STU)

Zeit	Kurs	Umsatz (Stk)
21:57:11	180,700
21:47:22	180,700
21:33:37	180,800
21:17:33	180,700
21:04:10	180,700
20:32:48	180,700
20:18:07	180,700
20:03:23	180,600
19:50:47	180,500
19:31:14	180,500
19:16:09	180,600
19:01:12	180,500
18:31:24	180,300
18:16:24	178,200
18:01:57	178,100
17:31:12	178,000
17:16:13	178,400
17:13:18	178,600	250
17:01:12	178,600
16:31:15	178,900
16:27:26	178,000	8
16:16:08	178,100
15:31:15	178,000
15:16:19	178,100
15:01:13	178,100
14:31:20	178,100
14:16:25	178,400
13:31:19	178,800
13:16:31	179,300
13:01:35	178,900
12:51:09	179,500
12:31:40	179,100
12:16:32	176,500
12:01:41	177,100
11:31:49	177,000

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Nachrichten zu Sartorius Stedim Biotech

23.04.26		Sartorius Stedim Biotech reports robust first-quarter results for fiscal 2026
22.04.26		Ausblick: Sartorius Stedim Biotech legt die Bilanz zum abgelaufenen Quartal vor
08.04.26		Erste Schätzungen: Sartorius Stedim Biotech veröffentlicht Zahlen zum vergangenen Quartal
30.03.26		Sartorius Stedim-Aktie: Goldman Sachs hebt auf 'Buy' - Zinsen drücken Kursziel
24.03.26		Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.
17.03.26		Sartorius Stedim Biotech sharpens strategy with biopharma focus and sets new mid-term growth targets
06.03.26		ANALYSE-FLASH: RBC hebt Sartorius Stedim Biotech auf 'Outperform' - Kaufchance
16.02.26		Sartorius Stedim Biotech releases Universal Registration Document 2025
16.02.26		Sartorius Stedim Biotech releases Universal Registration Document 2025

Analysen zu Sartorius Stedim Biotech

22.06.26	Sartorius Stedim Biotech Overweight
06.05.26	Sartorius Stedim Biotech Outperform
23.04.26	Sartorius Stedim Biotech Overweight
23.04.26	Sartorius Stedim Biotech Outperform
23.04.26	Sartorius Stedim Biotech Overweight

Weitere Meldungen

22:01		Rocket Lab Is Set to Acquire Satellite Telecom Giant Iridium for $8 BIllion
22:00		Down 35% on Artificial Intelligence (AI) Panic: Why Smart Investors Are Loading Up on Microsoft Stock
22:00		Has Micron Technology Become the New Nvidia?
21:55		Prediction: This Artificial Intelligence (AI) Stock Will Be Worth More Than SpaceX by the End of 2026
21:52		Should You Buy UnitedHealth Group Stock Before July 16?
21:46		Which Is the Better Global Real Estate ETF, Vanguard's VNQI or the iShares REET?
21:42		State Street's RWO or Xtrackers' HAUZ: Which Real Estate ETF Is the Better Buy?
21:36		Struggling With Rising Retirement Expenses in 2026? Here's What to Do.
21:35		This rare, widening gap between Big Tech and semiconductor stocks is flashing a warning for the broader market
21:26		Why Verizon Fell Today
21:19		Prime Members, This 40%-Off Laifen Hair Dryer Needs to Be Added to Your Cart
21:18		Why Cerebras Stock Is Skyrocketing Today
21:16		Should You Buy Netflix Stock Before July 16?
21:16		Bitcoin Reclaims $60,000 As Ethereum, XRP, Dogecoin Rise After Strategy Unveils BTC Monetization Plan
21:15		Alphabet Stock Investors: Here's the Most Important Metric to Follow
21:13		SpaceX Will Join the Nasdaq-100 on July 7. Here's What a $10,000 Investment Could Be Worth in December, According to History.
21:11		Gorilla Technology Stock Surges On Lifted Q2 Revenue Guidance
21:05		What's Going On With Tesla Stock Today?
21:05		SoFi Has Quietly Met the Bar for S&P 500 Inclusion. Here's What Index Entry Could Do for the Stock.
21:00		Is Nvidia Still a Millionaire-Maker Stock?
20:56		Why AST SpaceMobile Keeps Gaining
20:53		SpaceX Cracked the Nasdaq-100 in Just 15 Days — the Fastest Ever. Is It Time to Buy?
20:52		Which Is the Better Energy ETF, the Alerian MLP or VanEck's NLR Focused on Uranium and Nuclear?
20:50		Aegon, Lakemore Expand CLO Partnership With $12 Billion Growth Target
20:44		Why Applied Materials Shares Are Surging Monday
20:37		Cathie Wood's Ark Venture Fund Is Sitting on SpaceX, OpenAI, and Anthropic All at Once. Here's What Investors Need to Know.
20:33		BlackBerry Stock Is Trending Higher Today: What's Happening?
20:29		SpaceX Just Lost $600 Billion in Value in Less Than Two Weeks. That's Why I'm Buying Bitcoin.
20:28		AeroVironment Q4 Print: Drones In Demand, But Doubt In The Stock?
20:15		2 Reasons to Buy MP Materials Stock, and 1 Reason to Sell
20:13		What's Going On With Nebius Group Stock Monday?
20:10		Charter may be making ‘frenemies’ with SpaceX, and its stock is soaring
20:07		Down About 29%, Is Meta Stock a Buy, Sell, or Hold?
20:00		3 Inflation-Resistant Stocks Poised to Keep Winning Through Year-End
19:55		Why Is Wendy’s Stock Rising On Monday?
19:45		AMD Stock Is Crushing Nvidia's in 2026. Will That Continue?
19:43		BrewDog and Tilray Beer Add Canada to The World's Biggest Bar Tab as Canada Advances to the Next Round
19:43		Comcast’s Hollywood break-up marks its GE moment
19:43		Pride Month has great significance for those who feel invisible. In Slovenia, many LGBTQ+ people understand just what that means
19:40		Bitcoin-hoarder Strategy unveils $2bn buyback as share price tumbles
19:37		Applied Aerospace & Defense Gets Bullish BofA Securities Call On Space, Missile Demand
19:36		Velo3D Stock Is Gaining Today: What's Going On?
19:35		US Supreme Court vastly expands Trump's presidential power
19:28		Vanguard Total World Stock ETF vs FTSE Emerging Markets ETF. Which Global Stock Fund Is the Better Buy??
19:28		What's Going On With Palo Alto Networks Stock Monday?
19:22		Is Wall Street misreading the Fed? The hidden upside catalyst for tech and real-estate stocks.
19:19		Nasdaq 100 Soars As Semis Rebound, Tesla Jumps: Stock Market Today
19:13		Charter Communications Stock Is Soaring: What's Going On?
19:08		Honeywell Completes Aerospace Spin-Off And Reverse Split: What Shareholders Need To Know
19:04		AbbVie Extends Reach Across Dermatology Markets With Dual Regulatory Wins

1 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: IBERIABANK Oncobiologics Zhejiang Langdi Group Voicetel Communications Intellia Therapeutics

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	29.06.2026 22:30
Kaufwert:	EUR
	Hinzufügen Speichern

Sartorius Stedim Biotech Aktie

WKN DE: A2AJKS / ISIN: FR0013154002

Sartorius Stedim Biotech Times and Sales (STU)

Nachrichten zu Sartorius Stedim Biotech

Analysen zu Sartorius Stedim Biotech

Weitere Meldungen